News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24659)
Month
January (2721)
February (3480)
March (4381)
April (4039)
May (4871)
June (4841)
July (3188)
August (2609)
September (3140)
October (3520)
November (2936)
December (2392)
Day
2 (87)
5 (124)
6 (168)
7 (147)
8 (171)
9 (129)
12 (184)
13 (158)
14 (132)
15 (128)
16 (111)
17 (2)
20 (148)
21 (111)
22 (135)
23 (83)
26 (134)
27 (163)
28 (144)
29 (145)
30 (117)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
5
6
7
8
9
12
13
14
15
16
17
20
21
22
23
26
27
28
29
30
Business
Dr. Reddy’s Laboratories, Inc.’s Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 million
January 20, 2009
·
1 min read
Ipsen: “Creating the Future: New Challenges in Biology and Medicine”
January 20, 2009
·
1 min read
Business
Ablynx Expands Its Musculoskeletal Portfolio By Taking P&G Pharmaceuticals, Inc.'s Programme In-House
January 20, 2009
·
2 min read
Biotech Beach
CLX Medical, Inc. Announces Anticipated Schedule for Reverse Stock Split
January 20, 2009
·
3 min read
Business
AspenBio Pharma, Inc. Expands Leadership With Addition of Daryl J. Faulkner as Executive Chairman
January 20, 2009
·
4 min read
BioMidwest
AspenBio Pharma, Inc. Reports Preliminary Results of AppyScore(TM) Clinical Study
January 20, 2009
·
7 min read
Drug Development
Cleveland Biolabs Inc. Completes Dosing of Fourth Cohort in Initial Safety Study for Protectan CBLB502
January 20, 2009
·
2 min read
Business
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
January 20, 2009
·
5 min read
Business
DOR BioPharma, Inc. Announces Engagement of Amper, Politziner & Mattia, LLP as New Auditors
January 20, 2009
·
5 min read
GelStat Corporation’s CEO Issues Shareholder Update
January 20, 2009
·
4 min read
Previous
8 of 15
Next